SPEG Gene Centronuclear Myopathy Type 5 Genetic Test sale cost 4400 AED
ASPA Gene Canavan Disease Genetic Test sale cost 4400 AED ASPA Gene Canavan Disease Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
VLDLR Gene Cerebellar Hypoplasia and Mental Retardation with or without Quadrupedal Locomotion Type 1 Genetic Test sale cost 4400 AED VLDLR Gene Cerebellar Hypoplasia and Mental Retardation with or without Quadrupedal Locomotion Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SPEG Gene Centronuclear Myopathy Type 5 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SPEG Gene Centronuclear Myopathy Type 5 Genetic Test is a highly specialized diagnostic tool designed to identify mutations in the SPEG gene, which are linked to Centronuclear Myopathy Type 5 (CNM5). This condition is a rare genetic disorder characterized by muscle weakness and abnormalities in the placement of nuclei within muscle cells, leading to significant motor function impairment. Early detection through this genetic test is crucial for managing symptoms and planning treatment strategies.

The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability of results. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. Through this test, individuals at risk or showing symptoms of CNM5 can gain valuable insights into their genetic makeup, allowing for informed medical and lifestyle decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SPEG Gene Centronuclear Myopathy Type 5 Genetic Test

At DNA Labs UAE, we offer the SPEG Gene Centronuclear Myopathy Type 5 Genetic Test at a cost of AED 4400.0. This test is used to diagnose and manage centronuclear myopathy type 5, a rare genetic disorder that affects muscle function.

Test Components

The SPEG Gene Centronuclear Myopathy Type 5 Genetic Test includes the following components:

  • NGS Technology
  • Neurological Disorders Test Type
  • Genetics Test Department

Sample Condition

The test requires a sample of either blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

Once the sample is received, the report will be delivered within 3 to 4 weeks.

Method

The test utilizes NGS (Next-Generation Sequencing) technology to analyze the SPEG gene.

Doctor and Test Department

The test is performed by a neurologist in our Genetics Test Department.

Pre Test Information

Before undergoing the SPEG Gene Centronuclear Myopathy Type 5 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the disorder.

Test Details

The SPEG gene is associated with centronuclear myopathy type 5, a rare genetic disorder characterized by muscle weakness and wasting, particularly in the skeletal muscles. The NGS genetic test analyzes the SPEG gene to identify any mutations or variants that may be linked to the disorder.

This test is essential for diagnosing centronuclear myopathy type 5 and provides crucial information for managing the condition. It can also be used for carrier testing and family planning purposes.

Test Name SPEG Gene Centronuclear myopathy type 5 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SPEG Gene Centronuclear myopathy type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SPEG Gene Centronuclear myopathy type 5
Test Details

The SPEG gene is associated with centronuclear myopathy type 5, a rare genetic disorder that affects muscle function. The disorder is characterized by muscle weakness and wasting, particularly in the skeletal muscles. The NGS genetic test is a type of genetic testing that uses next-generation sequencing technology to analyze the SPEG gene and identify any mutations or variants that may be associated with centronuclear myopathy type 5. This test can help diagnose the disorder and provide important information for managing the condition. It may also be used for carrier testing and family planning purposes.

SKU: TEST-1142 Category:

Related products